MDS | Tumor

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Drug Duo Is Efficacious in Treating Posttransplant GVHD

February 24th 2024, 3:00pm

Article

Jakafi plus Rezurock showed promise in treating graft-versus-host disease in patients who underwent undergone allogeneic hematopoietic cell transplantation.

The Hardest Decision I Ever Made Because of Cancer

January 30th 2024, 6:00pm

Article

A cancer survivor described the agony of making a life-or-death decision.

Oral Inqovi Safe and Effective Alternative MDS, CMML Treatment

January 29th 2024, 8:00pm

Article

Findings from the ASCERTAIN trial support the use of oral Inqovi for adults with intermediate- and high-risk myelodysplastic syndromes (MDS) such as chronic myelomonocytic leukemia (CMML).

Financial Burdens Harm Quality of Life After Stem Cell Transplants

January 16th 2024, 4:00pm

Article

Financial burdens from medical costs negatively affect quality of life in patients who have received stem cell transplants, recent research showed.

First Patient Receives HT-6184 in Phase 2a Trial for Low-Risk MDS

December 22nd 2023, 10:00pm

Article

A phase 2a trial administered the novel drug HT-6184 to its first patient with lower-risk myelodysplastic syndromes.

Orca-T Shows Promise in Intermediate-/High-Risk MDS

December 10th 2023, 10:00pm

Article

The stem cell thrapy, Orca-T led to promising relapse-free and overall survival rates in patients with intermediate- to high-risk myelodysplastic syndrome.

Tibsovo Represents ‘Potential Option in This Space’ for MDS Subset

November 20th 2023, 8:00pm

Article

The FDA recently approved Tibsovo for relapsed/refractory MDS with an IDH1 mutation, a treatment option for a disease subset with no options before this approval.

My Hospital Family During Cancer

November 16th 2023, 6:00pm

Article

My visits to the local cancer center were very impactful as a cancer survivor, and I consider that staff a part of my family.

Patrick Dempsey Reflects on His Nonprofit, ‘General Hospital’ Star Talks Cancer and More

November 10th 2023, 4:00pm

Article

From actor Patrick Dempsey saying that his late mother would be proud of his work at The Dempsey Center to a “General Hospital” actor discussing his cancer treatments, here’s what’s happening in the oncology space this week.

FDA Approves Tibsovo for Patients with R/R Myelodysplastic Syndromes

October 24th 2023, 8:55pm

Article

The Food and Drug Administration approved Tibsovo for patients with relapsed or refractory myelodysplastic syndromes with a susceptible isocitrate dehydrogenase-1 mutation.